Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bém

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|October 8, 2022
Telemedicine in diabetologyRobert Bém
Vnitrni Lekarstvi|March 17, 2023
Diabetic foot infection - diagnosis and treatmentRobert Bém
Pharmaceuticals (Basel, Switzerland)|March 4, 2014
Lucifensins, the Insect Defensins of Biomedical Importance: The Story behind Maggot TherapyVáclav Ceřovský, Robert Bém
Vnitrni Lekarstvi|September 18, 2020
Diabetic footRobert Bém, Michal Dubský, Vladimíra Fejfarová, et al.
Drugs & Aging|August 11, 2025
Charcot foot disease: A new approachMichal Dubský, Robert Bém, Dominika Sojáková, et al.
Cellular and Molecular Life Sciences : CMLS|November 19, 2009
Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericataVáclav Cerovský, Jan Zdárek, Vladimír Fucík, et al.
Diabetes, Obesity & Metabolism|March 31, 2026
Artificial Intelligence in Diabetes CareMichal Dubský, Michaela Liegertová, Robert Bém, et al.
Journal of the American Podiatric Medical Association|January 18, 2006
Power spectral analysis of heart rate variability in patients with Charcot's neuroarthropathyAlexandra Jirkovská, Petr Boucek, Stephanie Wu, et al.
Diabetes Technology & Therapeutics|March 25, 2025
Glucose Control in Type 1 Diabetes after Pancreas Transplantation: Does Automated Delivery Offer Comparable Results?Martina Zahradnická, Lenka Nemétová, Michal Kahle, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 26, 2004
[Optimization of amoxicillin/clavulanate therapy based on pharmacokinetic/pharmacodynamic parameters in patients with diabetic foot infection]Josef Sedivý, Vladimír Petkov, Alexandra Jirkovská, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|October 8, 2022
Telemedicine in diabetologyRobert Bém
Vnitrni Lekarstvi|March 17, 2023
Diabetic foot infection - diagnosis and treatmentRobert Bém
Pharmaceuticals (Basel, Switzerland)|March 4, 2014
Lucifensins, the Insect Defensins of Biomedical Importance: The Story behind Maggot TherapyVáclav Ceřovský, Robert Bém
Vnitrni Lekarstvi|September 18, 2020
Diabetic footRobert Bém, Michal Dubský, Vladimíra Fejfarová, et al.
Drugs & Aging|August 11, 2025
Charcot foot disease: A new approachMichal Dubský, Robert Bém, Dominika Sojáková, et al.
Cellular and Molecular Life Sciences : CMLS|November 19, 2009
Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericataVáclav Cerovský, Jan Zdárek, Vladimír Fucík, et al.
Diabetes, Obesity & Metabolism|March 31, 2026
Artificial Intelligence in Diabetes CareMichal Dubský, Michaela Liegertová, Robert Bém, et al.
Journal of the American Podiatric Medical Association|January 18, 2006
Power spectral analysis of heart rate variability in patients with Charcot's neuroarthropathyAlexandra Jirkovská, Petr Boucek, Stephanie Wu, et al.
Diabetes Technology & Therapeutics|March 25, 2025
Glucose Control in Type 1 Diabetes after Pancreas Transplantation: Does Automated Delivery Offer Comparable Results?Martina Zahradnická, Lenka Nemétová, Michal Kahle, et al.
Klinicka Mikrobiologie a Infekcni Lekarstvi|August 26, 2004
[Optimization of amoxicillin/clavulanate therapy based on pharmacokinetic/pharmacodynamic parameters in patients with diabetic foot infection]Josef Sedivý, Vladimír Petkov, Alexandra Jirkovská, et al.
Pageof 3